Megan Pollack, PharmD, BCOP

Director, Oncology Strategy & Communications
Cencora

Poster(s):

• (308) A survey of healthcare decision maker (HCDM) formulary management perspectives in crowded oncologic markets: a focus on advanced non-small cell lung cancer (aNSCLC) and relapsed/refractory multiple myeloma (RRMM)
  Wednesday, October 29, 2025